Wanbury — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Wanbury holds 42.98% of the company. At a market capitalisation of ₹670 cr, that holding is worth ₹288 cr.

Promoter stake

42.98%

Value of holding

₹288 cr

Market cap

₹670 cr

Stake change

+3.08%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
39.90%—
Q4-2021
39.89%—
Q1-2022
39.89%—
Q2-2022
39.85%—
Q3-2022
39.85%—
Q4-2022
39.84%—
Q1-2023
39.84%—
Q2-2023
39.84%—
Q3-2023
39.80%—
Q4-2023
39.79%—
Q1-2024
39.79%—
Q2-2024
39.79%—
Q3-2024
39.77%—
Q4-2024
39.76%—
Q1-2025
39.76%—
Q2-2025
39.63%—
Q3-2025
43.09%—
Q4-2025
43.07%—
Q1-2026
43.02%—
Q2-2026
43.02%—
Q3-2026
42.98%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Wanbury's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.